NIH Director's New Innovator Award
Supports early-stage researchers with transformative ideas in high-risk biomedical studies.
The NIH Director's New Innovator Award is part of the NIH Common Fund's High-Risk, High-Reward (HRHR) Research Program. Established in 2007, the award is specifically reserved for Early Stage Investigators — researchers who have completed their terminal degree or postdoctoral clinical training within the past ten years — and supports bold, innovative biomedical or behavioral research proposals tha…
Funds Early Stage Investigators within ten years of their terminal degree to pursue bold, high-risk biomedical or behavioral research, awarding $475,000 per year for five years.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
More from NIH Common Fund
All grants from this funder →CARE for Health — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports integrating clinical research into primary care environments through rural-focused network models.
Complement-ARIE — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports development of human-based new approach methodologies replacing animal models in relevant research.
Human Virome Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Offers exploration of the healthy human virome and virus host interactions across translational studies.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
Replication Initiative — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Funds independent validation of biomedical findings to strengthen reproducibility in research.
NIH Director's Early Independence Award
🇺🇸NIH Common Fund · United States
Funds a scientist to skip the postdoc entirely and run their own lab straight after the doctorate — ten awards of $350,000 each.
Similar grants
Browse the directory →
NIH SBIR Direct-to-Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses moving directly into major development when early biomedical feasibility is already established.
NIH SBIR Phase II
🇺🇸NIH SEED · United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIH SBIR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses advancing validated biomedical innovations through substantial full development execution.
NIH STTR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small-business and research-partner teams advancing biomedical projects already proven in early studies.
NEI SBIR Phase II — R&D
🇺🇸NEI · United States
Supports United States. small businesses scaling vision concepts into full development pathways.
NEI STTR Phase II — R&D
🇺🇸NEI · United States
Funds collaborative small-business partnerships to mature vision innovation into market-ready healthcare technologies.